{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:38:56Z","timestamp":1793741936748,"version":"4.6.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55659-z","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:35:00Z","timestamp":1735853700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade glioma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-2261","authenticated-orcid":false,"given":"Anahita","family":"Fathi Kazerooni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-5694","authenticated-orcid":false,"given":"Adam","family":"Kraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal S.","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meen Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arastoo","family":"Vossough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana M.","family":"Familiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-5427","authenticated-orcid":false,"given":"Deep","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kesherwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-9266","authenticated-orcid":false,"given":"Run","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Mahtabfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-9473","authenticated-orcid":false,"given":"Sina","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-8589","authenticated-orcid":false,"given":"Yiran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-7537","authenticated-orcid":false,"given":"Alex","family":"Sickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Lueder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-2572","authenticated-orcid":false,"given":"Saksham","family":"Phul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Koptyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip B.","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7699-2059","authenticated-orcid":false,"given":"Yuanquan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1025-8561","authenticated-orcid":false,"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-9357","authenticated-orcid":false,"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-4552","authenticated-orcid":false,"given":"Ali","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"55659_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noac161","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro Oncol. 24, iii1\u2013iii38 (2022).","journal-title":"Neuro Oncol."},{"key":"55659_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"55659_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-00902-z","volume":"8","author":"S Ryall","year":"2020","unstructured":"Ryall, S., Tabori, U. & Hawkins, C. Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol. Commun. 8, 1\u201322 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"55659_CR4","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.neo.2022.100857","volume":"36","author":"N Manoharan","year":"2023","unstructured":"Manoharan, N., Liu, K. X., Mueller, S., Haas-Kogan, D. A. & Bandopadhayay, P. Pediatric low-grade glioma: targeted therapeutics and clinical trials in the molecular era. Neoplasia 36, 100857 (2023).","journal-title":"Neoplasia"},{"key":"55659_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nox141","volume":"20","author":"DT Jones","year":"2018","unstructured":"Jones, D. T. et al. Pediatric low-grade gliomas: next biologically driven steps. Neuro Oncol. 20, 160\u2013173 (2018).","journal-title":"Neuro Oncol."},{"key":"55659_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00413-9","volume":"7","author":"N Khalili","year":"2023","unstructured":"Khalili, N. et al. Radiomics for characterization of the glioma immune microenvironment. NPJ Precis. Oncol. 7, 59 (2023).","journal-title":"NPJ Precis. Oncol."},{"key":"55659_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. & Joyce, J. A. The microenvironmental landscape of brain tumors. Cancer Cell 31, 326\u2013341 (2017).","journal-title":"Cancer Cell"},{"key":"55659_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmri.26907","volume":"52","author":"A Fathi Kazerooni","year":"2020","unstructured":"Fathi Kazerooni, A., Bakas, S., Saligheh Rad, H. & Davatzikos, C. Imaging signatures of glioblastoma molecular characteristics: a radiogenomics review. J. Magn. Reson. Imaging 52, 54\u201369 (2020).","journal-title":"J. Magn. Reson. Imaging"},{"key":"55659_CR9","doi-asserted-by":"crossref","unstructured":"Tak, D. et al. Noninvasive molecular subtyping of pediatric low-grade glioma with self-supervised transfer learning. Radiol Artif Intell. 6, e230333 (2024).","DOI":"10.1148\/ryai.230333"},{"key":"55659_CR10","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3174\/ajnr.A7574","volume":"43","author":"A Trasolini","year":"2022","unstructured":"Trasolini, A. et al. MR imaging of pediatric low-grade gliomas: pretherapeutic differentiation of BRAF V600E mutation, BRAF fusion, and wild-type tumors in patients without neurofibromatosis-1. Am. J. Neuroradiol. 43, 1196\u20131201 (2022).","journal-title":"Am. J. Neuroradiol."},{"key":"55659_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3174\/ajnr.A6998","volume":"42","author":"M Wagner","year":"2021","unstructured":"Wagner, M. et al. Radiomics of pediatric low-grade gliomas: toward a pretherapeutic differentiation of BRAF-mutated and BRAF-fused tumors. Am. J. Neuroradiol. 42, 759\u2013765 (2021).","journal-title":"Am. J. Neuroradiol."},{"key":"55659_CR12","doi-asserted-by":"crossref","unstructured":"Kudus, K. et al. Increased confidence of radiomics facilitating pretherapeutic differentiation of BRAF-altered pediatric low-grade glioma. Eur. Radiol. 34, 2772\u20132781 (2023).","DOI":"10.1007\/s00330-023-10267-1"},{"key":"55659_CR13","doi-asserted-by":"publisher","first-page":"100846","DOI":"10.1016\/j.neo.2022.100846","volume":"35","author":"JV Lilly","year":"2023","unstructured":"Lilly, J. V. et al. The children\u2019s brain tumor network (CBTN)-accelerating research in pediatric central nervous system tumors through collaboration and open science. Neoplasia 35, 100846 (2023).","journal-title":"Neoplasia"},{"key":"55659_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"55659_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"55659_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran, D., Sirota, M. & Butte, A. J. Systematic pan-cancer analysis of tumour purity. Nat. Commun. 6, 8971 (2015).","journal-title":"Nat. Commun."},{"key":"55659_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-2100-3","volume":"17","author":"D Damotte","year":"2019","unstructured":"Damotte, D. et al. The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. J. Transl. Med. 17, 1\u201310 (2019).","journal-title":"J. Transl. Med."},{"key":"55659_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 1\u201314 (2017).","journal-title":"Genome Biol."},{"key":"55659_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle, A. et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 21, 1353\u20131365 (2020).","journal-title":"Lancet Oncol."},{"key":"55659_CR20","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","volume":"27","author":"L Marcus","year":"2021","unstructured":"Marcus, L. et al. FDA approval summary: pembrolizumab for the treatment of tumor mutational burden\u2013high solid tumors. Clin. Cancer Res. 27, 4685\u20134689 (2021).","journal-title":"Clin. Cancer Res."},{"key":"55659_CR21","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00159","volume":"6","author":"AA Kraya","year":"2022","unstructured":"Kraya, A. A. et al. PTEN loss and BRCA1 promoter Hypermethylation negatively predict for immunogenicity in BRCA-Deficient ovarian Cancer. JCO Precis. Oncol. 6, e2100159 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"55659_CR22","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1158\/1078-0432.CCR-18-0468","volume":"25","author":"AA Kraya","year":"2019","unstructured":"Kraya, A. A. et al. Genomic signatures predict the immunogenicity of BRCA-deficient breast cancerimmunogenetic signatures of BRCA1\/2 breast cancer. Clin. Cancer Res. 25, 4363\u20134374 (2019).","journal-title":"Clin. Cancer Res."},{"key":"55659_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","volume":"49","author":"J Li","year":"2018","unstructured":"Li, J. et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity 49, 178\u2013193 e177 (2018).","journal-title":"Immunity"},{"key":"55659_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-018-0367-1","volume":"6","author":"P Danaher","year":"2018","unstructured":"Danaher, P. et al. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). J. Immunother. Cancer 6, 1\u201317 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"55659_CR25","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s10143-022-01871-8","volume":"45","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. Correlation analysis of tumor purity with clinicopathological, molecular, and imaging features in high-grade gliomas. Neurosurg. Rev. 45, 3699\u20133708 (2022).","journal-title":"Neurosurg. Rev."},{"key":"55659_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","volume":"37","author":"S Ryall","year":"2020","unstructured":"Ryall, S. et al. Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37, 569\u2013583 e565 (2020).","journal-title":"Cancer Cell"},{"key":"55659_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ajhg.2009.03.010","volume":"84","author":"HV Firth","year":"2009","unstructured":"Firth, H. V. et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am. J. Hum. Genet. 84, 524\u2013533 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"55659_CR28","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"55659_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00011","volume":"1","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 1, 1\u201316 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"55659_CR30","doi-asserted-by":"publisher","first-page":"D1230","DOI":"10.1093\/nar\/gkac979","volume":"51","author":"K Krysiak","year":"2023","unstructured":"Krysiak, K. et al. CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase. Nucleic Acids Res. 51, D1230\u2013D1241 (2023).","journal-title":"Nucleic Acids Res."},{"key":"55659_CR31","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/brain\/aww079","volume":"139","author":"M Synofzik","year":"2016","unstructured":"Synofzik, M. et al. SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: a large multi-centre study. Brain 139, 1378\u20131393 (2016).","journal-title":"Brain"},{"key":"55659_CR32","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1158\/0008-5472.CAN-11-0180","volume":"71","author":"DL Masica","year":"2011","unstructured":"Masica, D. L. & Karchin, R. Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res. 71, 4550\u20134561 (2011).","journal-title":"Cancer Res."},{"key":"55659_CR33","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/biomedicines9121819","volume":"9","author":"Y-D Chu","year":"2021","unstructured":"Chu, Y.-D. et al. SYNE1 exonic variant rs9479297 contributes to concurrent hepatocellular and transitional cell carcinoma double primary cancer. Biomedicines 9, 1819 (2021).","journal-title":"Biomedicines"},{"key":"55659_CR34","first-page":"6582014","volume":"2018","author":"M Urbini","year":"2018","unstructured":"Urbini, M. et al. Whole exome sequencing uncovers germline variants of cancer-related genes in sporadic pheochromocytoma. Int. J. Genom. 2018, 6582014 (2018).","journal-title":"Int. J. Genom."},{"key":"55659_CR35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/NEN.0000000000000213","volume":"74","author":"AP Becker","year":"2015","unstructured":"Becker, A. P. et al. KIAA1549: BRAF gene fusion and FGFR1 hotspot mutations are prognostic factors in pilocytic astrocytomas. J. Neuropathol. Exp. Neurol. 74, 743\u2013754 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"55659_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","volume":"100","author":"TB Geijtenbeek","year":"2000","unstructured":"Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell\u2013specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575\u2013585 (2000).","journal-title":"Cell"},{"key":"55659_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1593\/neo.11024","volume":"13","author":"M Candolfi","year":"2011","unstructured":"Candolfi, M. et al. B cells are critical to T-cell\u2014mediated antitumor immunity induced by a combined immune-stimulatory\/conditionally cytotoxic therapy for glioblastoma. Neoplasia 13, 947\u2013IN923 (2011).","journal-title":"Neoplasia"},{"key":"55659_CR38","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1182\/blood-2007-10-120071","volume":"111","author":"J Kunisawa","year":"2008","unstructured":"Kunisawa, J. et al. Sphingosine 1-phosphate\u2013dependent trafficking of peritoneal B cells requires functional NF\u03baB-inducing kinase in stromal cells. Blood 111, 4646\u20134652 (2008).","journal-title":"Blood"},{"key":"55659_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4049\/jimmunol.1401514","volume":"195","author":"HD Brightbill","year":"2015","unstructured":"Brightbill, H. D. et al. Conditional deletion of NF-\u03baB\u2013inducing kinase (NIK) in adult mice disrupts mature B cell survival and activation. J. Immunol. 195, 953\u2013964 (2015).","journal-title":"J. Immunol."},{"key":"55659_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jcp.57.1.6","volume":"57","author":"N Nathoo","year":"2004","unstructured":"Nathoo, N., Barnett, G. & Golubic, M. The eicosanoid cascade: possible role in gliomas and meningiomas. J. Clin. Pathol. 57, 6\u201313 (2004).","journal-title":"J. Clin. Pathol."},{"key":"55659_CR41","doi-asserted-by":"publisher","first-page":"e163448","DOI":"10.1172\/JCI163448","volume":"133","author":"J Miska","year":"2023","unstructured":"Miska, J. & Chandel, N. S. Targeting fatty acid metabolism in glioblastoma. J. Clin. Investig. 133, e163448 (2023).","journal-title":"J. Clin. Investig."},{"key":"55659_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-020-2297-3","volume":"11","author":"AL Cruz","year":"2020","unstructured":"Cruz, A. L., Barreto, Ed. A., Fazolini, N. P., Viola, J. P. & Bozza, P. T. Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis. 11, 105 (2020).","journal-title":"Cell Death Dis."},{"key":"55659_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106206","volume":"179","author":"T Lopatina","year":"2022","unstructured":"Lopatina, T. et al. IL-3 signalling in the tumour microenvironment shapes the immune response via tumour endothelial cell-derived extracellular vesicles. Pharmacol. Res. 179, 106206 (2022).","journal-title":"Pharmacol. Res."},{"key":"55659_CR44","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-14-2379","volume":"75","author":"R Zaynagetdinov","year":"2015","unstructured":"Zaynagetdinov, R. et al. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment. Cancer Res. 75, 1624\u20131634 (2015).","journal-title":"Cancer Res."},{"key":"55659_CR45","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.3390\/cancers13215284","volume":"13","author":"S Khan","year":"2021","unstructured":"Khan, S. et al. Intrinsic interferon signaling regulates the cell death and mesenchymal phenotype of glioblastoma stem cells. Cancers 13, 5284 (2021).","journal-title":"Cancers"},{"key":"55659_CR46","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.3390\/cancers14184390","volume":"14","author":"AM-S Ko","year":"2022","unstructured":"Ko, A. M.-S., Tu, H.-P. & Ko, Y.-C. Systematic review of the role of alpha-protein kinase 1 in cancer and cancer-related inflammatory diseases. Cancers 14, 4390 (2022).","journal-title":"Cancers"},{"key":"55659_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01517-z","volume":"20","author":"J Li","year":"2020","unstructured":"Li, J. et al. The relationship between TRAF6 and tumors. Cancer Cell Int. 20, 1\u201312 (2020).","journal-title":"Cancer Cell Int."},{"key":"55659_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36124-9","volume":"14","author":"R Salam","year":"2023","unstructured":"Salam, R. et al. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma. Nat. Commun. 14, 441 (2023).","journal-title":"Nat. Commun."},{"key":"55659_CR49","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00262-019-02423-8","volume":"68","author":"A Vidyarthi","year":"2019","unstructured":"Vidyarthi, A. et al. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity. Cancer Immunol. Immunother. 68, 1995\u20132004 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"55659_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12016-019-08753-w","volume":"58","author":"DEA Komi","year":"2020","unstructured":"Komi, D. E. A. & Redegeld, F. A. Role of mast cells in shaping the tumor microenvironment. Clin. Rev. Allergy Immunol. 58, 313\u2013325 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"55659_CR51","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Predicting individual prognosis and grade of patients with glioma based on preoperative eosinophil and neutrophil-to-lymphocyte ratio. Cancer Manag. Res. 12, 5793\u20135802 (2020).","DOI":"10.2147\/CMAR.S260695"},{"key":"55659_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/imcb.12225","volume":"97","author":"F Ren","year":"2019","unstructured":"Ren, F. et al. The R132H mutation in IDH 1 promotes the recruitment of NK cells through CX 3 CL 1\/CX 3 CR 1 chemotaxis and is correlated with a better prognosis in gliomas. Immunol. Cell Biol. 97, 457\u2013469 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"55659_CR53","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3389\/fimmu.2019.01767","volume":"10","author":"EK Holl","year":"2019","unstructured":"Holl, E. K. et al. Examining peripheral and tumor cellular immunome in patients with cancer. Front. Immunol. 10, 1767 (2019).","journal-title":"Front. Immunol."},{"key":"55659_CR54","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.ajpath.2012.07.033","volume":"181","author":"PH Domingues","year":"2012","unstructured":"Domingues, P. H. et al. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Am. J. Pathol. 181, 1749\u20131761 (2012).","journal-title":"Am. J. Pathol."},{"key":"55659_CR55","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.3390\/cells10123378","volume":"10","author":"IS Mauldin","year":"2021","unstructured":"Mauldin, I. S. et al. Proliferating CD8+ T cell infiltrates are associated with improved survival in glioblastoma. Cells 10, 3378 (2021).","journal-title":"Cells"},{"key":"55659_CR56","doi-asserted-by":"publisher","first-page":"574974","DOI":"10.3389\/fonc.2020.574974","volume":"10","author":"K Srinivasa","year":"2020","unstructured":"Srinivasa, K., Cross, K. A. & Dahiya, S. BRAF alteration in central and peripheral nervous system tumors. Front. Oncol. 10, 574974 (2020).","journal-title":"Front. Oncol."},{"key":"55659_CR57","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.3390\/cancers14174264","volume":"14","author":"D Talloa","year":"2022","unstructured":"Talloa, D. et al. BRAF and MEK targeted therapies in pediatric central nervous system tumors. Cancers 14, 4264 (2022).","journal-title":"Cancers"},{"key":"55659_CR58","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cancers11101618","volume":"11","author":"C Braicu","year":"2019","unstructured":"Braicu, C. et al. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers 11, 1618 (2019).","journal-title":"Cancers"},{"key":"55659_CR59","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-11-1243","volume":"71","author":"J Villanueva","year":"2011","unstructured":"Villanueva, J., Vultur, A. & Herlyn, M. Resistance to BRAF inhibitors: unraveling mechanisms and future treatment options. Cancer Res. 71, 7137\u20137140 (2011).","journal-title":"Cancer Res."},{"key":"55659_CR60","doi-asserted-by":"publisher","first-page":"30453","DOI":"10.18632\/oncotarget.8351","volume":"7","author":"CH Adelmann","year":"2016","unstructured":"Adelmann, C. H. et al. Comparative profiles of BRAF inhibitors: the paradox index as a predictor of clinical toxicity. Oncotarget 7, 30453 (2016).","journal-title":"Oncotarget"},{"key":"55659_CR61","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1200\/JCO.2013.52.1377","volume":"32","author":"S Hu-Lieskovan","year":"2014","unstructured":"Hu-Lieskovan, S., Robert, L., Moreno, B. H. & Ribas, A. Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges. J. Clin. Oncol. 32, 2248 (2014).","journal-title":"J. Clin. Oncol."},{"key":"55659_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001066","volume":"8","author":"MH Robinson","year":"2020","unstructured":"Robinson, M. H. et al. Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma. J. Immunother. Cancer 8, e001066 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"55659_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/jnen\/nlz119","volume":"79","author":"AM Martin","year":"2020","unstructured":"Martin, A. M. et al. PD-L1 expression in pediatric low-grade gliomas is independent of BRAF V600E mutational status. J. Neuropathol. Exp. Neurol. 79, 74\u201385 (2020).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"55659_CR64","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1172\/JCI139080","volume":"130","author":"JY Chan","year":"2020","unstructured":"Chan, J. Y. et al. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma. J. Clin. Investig. 130, 5833\u20135846 (2020).","journal-title":"J. Clin. Investig."},{"key":"55659_CR65","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1158\/1078-0432.CCR-20-1923","volume":"26","author":"W Schroth","year":"2020","unstructured":"Schroth, W. et al. Gene expression signatures of BRCAness and tumor inflammation define subgroups of early-stage hormone receptor\u2013positive breast cancer patients. Clin. Cancer Res. 26, 6523\u20136534 (2020).","journal-title":"Clin. Cancer Res."},{"key":"55659_CR66","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.omto.2020.12.012","volume":"20","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Classification of pediatric gliomas based on immunological profiling: Implications for immunotherapy strategies. Mol. Ther. Oncolytics 20, 34\u201347 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"55659_CR67","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3390\/cancers12103039","volume":"12","author":"JB-K Hsu","year":"2020","unstructured":"Hsu, J. B.-K. et al. Radiomic immunophenotyping of GSEA-assessed immunophenotypes of glioblastoma and its implications for prognosis: a feasibility study. Cancers 12, 3039 (2020).","journal-title":"Cancers"},{"key":"55659_CR68","doi-asserted-by":"publisher","first-page":"101244","DOI":"10.18632\/oncotarget.20643","volume":"8","author":"S Narang","year":"2017","unstructured":"Narang, S. et al. Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma. Oncotarget 8, 101244 (2017).","journal-title":"Oncotarget"},{"key":"55659_CR69","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00262-020-02836-w","volume":"70","author":"AR Kim","year":"2021","unstructured":"Kim, A. R. et al. Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values. Cancer Immunol. Immunother. 70, 1995\u20132008 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"55659_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.823812","volume":"12","author":"A Salvalaggio","year":"2022","unstructured":"Salvalaggio, A. et al. Magnetic resonance imaging correlates of immune microenvironment in glioblastoma. Front. Oncol. 12, 823812 (2022).","journal-title":"Front. Oncol."},{"key":"55659_CR71","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.21037\/qims-23-126","volume":"13","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. Correlation of tumor-associated macrophage infiltration in glioblastoma with magnetic resonance imaging characteristics: a retrospective cross-sectional study. Quant. Imaging Med. Surg. 13, 5958 (2023).","journal-title":"Quant. Imaging Med. Surg."},{"key":"55659_CR72","doi-asserted-by":"crossref","unstructured":"Fathi Kazerooni, A. et al. The Radiogenomic and Spatiogenomic Landscapes of Glioblastoma, and Their Relationship to Oncogenic Drivers. bioRxiv, 2022.2012. 2015.517767 (2022).","DOI":"10.1101\/2022.12.15.517767"},{"key":"55659_CR73","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","volume":"30","author":"JL Ater","year":"2012","unstructured":"Ater, J. L. et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children\u2019s Oncology Group. J. Clin. Oncol. 30, 2641 (2012).","journal-title":"J. Clin. Oncol."},{"key":"55659_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/MOP.0000000000000717","volume":"31","author":"P de Blank","year":"2019","unstructured":"de Blank, P., Bandopadhayay, P., Haas-Kogan, D., Fouladi, M. & Fangusaro, J. Management of pediatric low-grade glioma. Curr. Opin. Pediatr. 31, 21 (2019).","journal-title":"Curr. Opin. Pediatr."},{"key":"55659_CR75","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/jon.13017","volume":"32","author":"BL Serrallach","year":"2022","unstructured":"Serrallach, B. L. et al. Neuroimaging in cerebellar ataxia in childhood: a review. J. Neuroimaging 32, 825\u2013851 (2022).","journal-title":"J. Neuroimaging"},{"key":"55659_CR76","unstructured":"Shapiro, J. A. et al. OpenPBTA: the open pediatric brain tumor atlas. Cell Genom. 3, 100340 (2023)."},{"key":"55659_CR77","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"55659_CR78","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. GENCODE 2021. Nucleic Acids Res. 49, D916\u2013D923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"55659_CR79","doi-asserted-by":"crossref","unstructured":"Sturm, G., Finotello, F. & List, M. Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data. In Bioinformatics for Cancer Immunotherapy. Methods in Molecular Biology Vol. 2120 (eds Boegel, S.) (Humana, New York, NY, 2020).","DOI":"10.1007\/978-1-0716-0327-7_16"},{"key":"55659_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"55659_CR81","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. BioRxiv, https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"55659_CR82","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"55659_CR83","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"55659_CR84","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290\u2013299 (2021).","journal-title":"Nature"},{"key":"55659_CR85","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/humu.21517","volume":"32","author":"X Liu","year":"2011","unstructured":"Liu, X., Jian, X. & Boerwinkle, E. dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum. Mutat. 32, 894\u2013899 (2011).","journal-title":"Hum. Mutat."},{"key":"55659_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-00803-9","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu, X., Li, C., Mou, C., Dong, Y. & Tu, Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 12, 1\u20138 (2020).","journal-title":"Genome Med."},{"key":"55659_CR87","doi-asserted-by":"publisher","first-page":"D835","DOI":"10.1093\/nar\/gkz972","volume":"48","author":"MJ Landrum","year":"2020","unstructured":"Landrum, M. J. et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 48, D835\u2013D844 (2020).","journal-title":"Nucleic Acids Res."},{"key":"55659_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson, P. D. et al. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum. Genet. 133, 1\u20139 (2014).","journal-title":"Hum. Genet."},{"key":"55659_CR89","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad027","volume":"5","author":"A Fathi Kazerooni","year":"2023","unstructured":"Fathi Kazerooni, A. et al. Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study. Neuro Oncol. Adv. 5, vdad027 (2023).","journal-title":"Neuro Oncol. Adv."},{"key":"55659_CR90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91\u2013118 (2003).","journal-title":"Mach. Learn."},{"key":"55659_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/bioinformatics\/btt632","volume":"30","author":"Y Si","year":"2014","unstructured":"Si, Y., Liu, P., Li, P. & Brutnell, T. P. Model-based clustering for RNA-seq data. Bioinformatics 30, 197\u2013205 (2014).","journal-title":"Bioinformatics"},{"key":"55659_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20430-7","volume":"12","author":"L Cantini","year":"2021","unstructured":"Cantini, L. et al. Benchmarking joint multi-omics dimensionality reduction approaches for the study of cancer. Nat. Commun. 12, 124 (2021).","journal-title":"Nat. Commun."},{"key":"55659_CR93","first-page":"226","volume":"96","author":"M Ester","year":"1996","unstructured":"Ester, M., Kriegel, H.-P., Sander, J. & Xu, X. A density-based algorithm for discovering clusters in large spatial databases with noise. KDD\u201896 Proc. Second Int. Conf. Knowl. Discov. Data Min. 96, 226\u2013231 (1996).","journal-title":"KDD\u201896 Proc. Second Int. Conf. Knowl. Discov. Data Min."},{"key":"55659_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea, S., Josse, J. & Husson, F. FactoMineR: an R package for multivariate analysis. J. Stat. Softw. 25, 1\u201318 (2008).","journal-title":"J. Stat. Softw."},{"key":"55659_CR95","doi-asserted-by":"publisher","unstructured":"Wickham, H. Data Analysis. In ggplot2. Use R! pp. 189\u2013201 (Springer, Cham, 2016) https:\/\/doi.org\/10.1007\/978-3-319-24277-4_9.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"55659_CR96","unstructured":"Nakazawa, M. fmsb: Functions for medical statistics book with some demographic data. R package version 0.7.6. (2024)."},{"key":"55659_CR97","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"55659_CR98","doi-asserted-by":"publisher","unstructured":"Fathi Kazerooni, A. et al. \u201cMultiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade glioma\u201d. pLGG Radioimmunomics and Clinicoradiomics. https:\/\/doi.org\/10.5281\/zenodo.13942516 (2024).","DOI":"10.5281\/zenodo.13942516"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55659-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55659-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55659-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T18:02:37Z","timestamp":1735927357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55659-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55659"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55659-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.18.24306046","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}